Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets (2023 - 2025)
Zhengye Biotechnology Holding's (ZYBT) quarterly Other Non-Current Assets came in at $988922.1 in Q4 2025, down 62.01% year-over-year from $2.6 million in Q4 2024, and down 58.27% quarter-over-quarter from $2.4 million in Q2 2025.
Analysis
Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Other Non-Current Assets for 3 consecutive years, with $988922.1 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Other Non-Current Assets fell 62.01% year-over-year to $988922.1 in Q4 2025; TTM through Dec 2025 was $988922.1, a 62.01% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, down 60.85% from the prior year.
- Other Non-Current Assets was $988922.1 for Q4 2025 at Zhengye Biotechnology Holding, down from $2.4 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $2.6 million in Q4 2024 and troughed at $903323.6 in Q4 2023.
- A 3-year average of $1.7 million and a median of $1.7 million in 2025 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets soared 188.16% in 2024 and sank 62.01% in 2025, its largest moves.
- Over 3 years, Other Non-Current Assets stood at $903323.6 in 2023, then soared by 188.16% to $2.6 million in 2024, then plunged by 62.01% to $988922.1 in 2025.
- The last three Other Non-Current Assets figures came in at $988922.1 (Q4 2025), $2.4 million (Q2 2025), and $2.6 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | 567.73 Mn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 384.00 Mn |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 304.00 Mn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 106.46 Mn |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | 31,658.00 |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | 988,922.10 |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 988,922.10 |
| Jun 30, 2025 | 2.37 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 903,323.61 |